Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $19.6200 (-4.43%) ($19.6200 - $20.7750) on Thu. Dec. 31, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.18% (three month average) | RSI | 18 | Latest Price | $19.6200(-4.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.7% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.09% in a week (0% probabilities). VIXM(-34%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.09% (StdDev 4.18%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $7.48(-61.88%) | Resistance Level | $22.7 | 5 Day Moving Average | $20.78(-5.58%) | 10 Day Moving Average | $21.47(-8.62%) | 20 Day Moving Average | $22.7(-13.57%) | To recent high | -25.4% | To recent low | 54.7% | Market Cap | $1.458b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |